Sales of targeted therapies overtook cytotoxics in 2006. Let's see what we can interpret from it.
Sales of the Top 20 cancer therapy brands in each of the seven major markets totaled $24.5 billion in 2006 and are forecast to grow at a CAGR of 6.6% ...